Research Article

Phylogenetic Groups of Escherichia coli Strains from Patients with Urinary Tract Infection in Iran Based on the New Clermont Phylotyping Method

Table 2

Prevalence of resistance among various phylogenetic groups of E. coli isolates.

Antibiotics by classAntibioticPhylogenetic groupTotal
B1B2FUDEClade ICA

AminoglycosidesGentamycin15 (10.7)3 (2.1)5 (3.6)1 (0.7)3 (2.1)1 (0.7)1 (0.7)29 (20.7)
Amikacin5 (3.6)1 (0.7)1 (0.7)7 (5)

Beta-lactamsAmoxicillin4 (2.9)50 (35.7)3 (2.1)31 (22.1)2 (1.4)9 (6.4)9 (6.4)6 (4.3)1 (0.7)115 (82.1)
Ampicillin4 (2.9)49 (35)3 (2.1)30 (21.4)1 (0.7)9 (6.4)9 (6.4)6 (4.3)1 (0.7)112 (80)
Cephalothin32 (22.9)3 (2.1)15 (10.7)5 (3.6)3 (2.1)4 (2.9)1 (0.7)63 (45)
Ceftriaxone29 (20.7)3 (2.1)15 (10.7)5 (3.6)3 (2.1)4 (2.9)1 (0.7)60 (42.9)
Cefotaxime29 (20.7)3 (2.1)14 (10)5 (3.6)3 (2.1)3 (2.1)1 (0.7)58 (41.4)
Ceftazidime22 (15.7)2 (1.4)10 (7.1)4 (2.9)3 (2.1)2 (1.4)1 (0.7)44 (31.4)
Ceftizoxime14 (10)1 (0.7)3 (2.1)2 (1.4)3 (2.1)1 (0.7)1 (0.7)25 (17.9)

SulfonamidesTrimethoprim-sulfamethoxazole1 (0.7)32 (22.9)2 (1.4)25 (17.9)2 (1.4)7 (5)6 (4.3)5 (3.6)1 (0.7)81 (57.9)

QuinolonesNalidixic acid1 (0.7)30 (21.4)3 (2.1)16 (11.4)5 (3.6)5 (3.6)2 (1.4)1 (0.7)63 (45)
Levofloxacin1 (0.7)26 (18.6)3 (2.1)11 (7.9)5 (3.6)1 (0.7)2 (1.4)1 (0.7)50 (35.7)
Norfloxacin1 (0.7)26 (18.6)3 (2.1)10 (7.1)5 (3.6)2 (1.4)1 (0.7)48 (34.3)
Ofloxacin1 (0.7)25 (17.9)3 (2.1)10 (7.1)5 (3.6)1 (0.7)2 (1.4)1 (0.7)48 (34.3)
Ciprofloxacin1 (0.7)26 (18.6)3 (2.1)9 (6.4)5 (3.6)1 (0.7)2 (1.4)1 (0.7)48 (34.3)

CarbapenemImipenem23 (16.4)3 (2.1)7 (5)4 (2.9)1 (0.7)2 (1.4)1 (0.7)41 (29.3)
Meropenem1 (0.7)1 (0.7)

NitrofuransNitrofurantoin1 (0.7)1 (0.7)2 (1.4)

Numbers in parenthesis are percentages.